Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-18

Clinical Trial Update: Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension [NA]

View source ↗

Summary

This update reports the termination of a clinical trial evaluating pulmonary artery denervation as a treatment for pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Pulmonary Arterial Hypertension | NA | Status: TERMINATED